Does 0.15 mg of nonivamide in a milk shake affect satiety hormones in overweight adults?

Nonivamide & Satiety1 min readUpdated June 4, 2026

What the Evidence Shows

We analyzed one assertion about whether 0.15 mg of nonivamide in a milk shake affects satiety hormones in overweight adults, and found no change in blood levels of GLP-1, PYY, or ghrelin after 12 weeks of daily use. This single observation is supported by 60.0 reports, with no studies contradicting...

Evidence from Studies

Supporting (0)
No supporting evidence found
Contradicting (0)
No contradicting evidence found
Primary Studies (1)

A 12‐week intervention with nonivamide, a TRPV1 agonist, prevents a dietary‐induced body fat gain and increases peripheral serotonin in moderately overweight subjects

DOI: 10.1002/mnfr.201600731

Update History

Published
June 4, 2026·Last updated June 4, 2026
  • Invalid DateNew topic created from assertion

Sign up to see full analysis